<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:admin="http://webns.net/mvcb/"
	xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">

	<channel>
		<title>TEIJIN PHARMA LIMITED | Notice</title>
		<link>/information/rss.xml</link>
		<description>Teijin Pharma Notice</description>
		<dc:language>ja</dc:language>
		<dc:creator>TEIJIN PHARMA LIMITED</dc:creator>
		
		<dc:date>Apr. 14, 2026</dc:date>
		
		<item>
		<title>[IMPORTANT] Notice Regarding Unauthorized Cross-border Distribution of Our Prescription Drugs Intended for the Japanese Market</title>
		<link>https://www.teijin-pharma.com/information/2026/20260414.html</link>
		<description></description>
		<dc:subject></dc:subject>
		<dc:creator>TEIJIN PHARMA LIMITED</dc:creator>
		<dc:date>Apr. 14, 2026</dc:date>
		</item>
		
		<item>
		<title>Teijin Pharma and Teijin Healthcare's Initiatives for COVID-19 (2)</title>
		<link>https://www.teijin-pharma.com/information/2020/202004142.html</link>
		<description></description>
		<dc:subject></dc:subject>
		<dc:creator>TEIJIN PHARMA LIMITED</dc:creator>
		<dc:date>Apr. 14, 2020</dc:date>
		</item>
		
		<item>
		<title>Teijin Pharma and Teijin Healthcare's Initiatives for COVID-19 (1)</title>
		<link>https://www.teijin-pharma.com/information/2020/202004141.html</link>
		<description></description>
		<dc:subject></dc:subject>
		<dc:creator>TEIJIN PHARMA LIMITED</dc:creator>
		<dc:date>Apr. 14, 2020</dc:date>
		</item>
		
		<item>
		<title>Teijin Pharma to Supply Ciclesonide for COVID-19 Clinical Research</title>
		<link>https://www.teijin-pharma.com/information/2020/20200310.html</link>
		<description></description>
		<dc:subject></dc:subject>
		<dc:creator>TEIJIN PHARMA LIMITED</dc:creator>
		<dc:date>Mar. 10, 2020</dc:date>
		</item>
		
		<item>
		<title>Teijin Pharma posts Project Stories Vol. 11 Innovative Rehabilitation Devices for Stroke Patients</title>
		<link>https://www.teijin-pharma.com/information/2019/20190328.html</link>
		<description></description>
		<dc:subject></dc:subject>
		<dc:creator>TEIJIN PHARMA LIMITED</dc:creator>
		<dc:date>Mar. 28, 2019</dc:date>
		</item>
		
		<item>
		<title>Teijin Board Elects Ichiro Watanabe as New President of Teijin Pharma</title>
		<link>https://www.teijin-pharma.com/information/2019/20190204.html</link>
		<description></description>
		<dc:subject></dc:subject>
		<dc:creator>TEIJIN PHARMA LIMITED</dc:creator>
		<dc:date>Feb. 04, 2019</dc:date>
		</item>
		
		<item>
		<title>Teijin Pharma posts Project Stories Vol. 10 Enabling First Class Care at Home</title>
		<link>https://www.teijin-pharma.com/information/2018/20181119.html</link>
		<description></description>
		<dc:subject></dc:subject>
		<dc:creator>TEIJIN PHARMA LIMITED</dc:creator>
		<dc:date>Nov. 19, 2018</dc:date>
		</item>
		
		<item>
		<title>Teijin Pharma posts Project Stories Vol. 9 Celebrating Teijin Pharma’s History as a Core Part of Teijin</title>
		<link>https://www.teijin-pharma.com/information/2018/20180727.html</link>
		<description></description>
		<dc:subject></dc:subject>
		<dc:creator>TEIJIN PHARMA LIMITED</dc:creator>
		<dc:date>Jul. 27, 2018</dc:date>
		</item>
		
		<item>
		<title>Teijin Pharma updates Project Stories Vol. 3 Building a Strong Platform in the Field of Bone and Joint Diseases</title>
		<link>https://www.teijin-pharma.com/information/2018/20180507.html</link>
		<description></description>
		<dc:subject></dc:subject>
		<dc:creator>TEIJIN PHARMA LIMITED</dc:creator>
		<dc:date>May. 07, 2018</dc:date>
		</item>
		
		<item>
		<title>Teijin Pharma updates Project Stories Vol. 1 A New Drug Born from R&D</title>
		<link>https://www.teijin-pharma.com/information/2017/20170331-1.html</link>
		<description></description>
		<dc:subject></dc:subject>
		<dc:creator>TEIJIN PHARMA LIMITED</dc:creator>
		<dc:date>Mar. 31, 2017</dc:date>
		</item>
		

	</channel>
</rss>